Menu
PacPremier
Magic Hour
Montecito
Loading...
You are here:  Home  >  'United Therapeutics'
Latest

MannKind stock slumps despite cashing in on United deal

By   /  Monday, April 1st, 2019  /  Biotech, Latest news  /  Comments Off on MannKind stock slumps despite cashing in on United deal

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Despite a recent $105 million contract, Mannkind files for yet another public offering

By   /  Thursday, December 20th, 2018  /  Biotech, Central Coast Health Watch, Latest news  /  Comments Off on Despite a recent $105 million contract, Mannkind files for yet another public offering

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

MannKind shifts to marketing inhaler technology

By   /  Friday, September 7th, 2018  /  Top Story  /  Comments Off on MannKind shifts to marketing inhaler technology

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →